Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection – a review

Lynda K. Beaupin(Roswell Park Comprehensive Cancer Center), Archie Bleyer(Oregon Health & Science University), Matthew J. Barth(Roswell Park Comprehensive Cancer Center), Raven Jaeger(Sigma-Tau Pharmaceuticals (United States)), Irene Franklin(Sigma-Tau Pharmaceuticals (United States)), Brian Schreiber(Sigma-Tau Pharmaceuticals (United States)), Priyanka Kamath(Sigma-Tau Pharmaceuticals (United States)), Bruce Bostrom(Minnesota West Community & Technical College)
Leukemia & lymphoma/Leukemia and lymphoma
September 19, 2016
10.1080/10428194.2016.1218004
Cited by 18

Related Papers

Breast Cancer Before Age 40 Years
|Seminars in Oncology|2009|795
A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study
|Blood|2002|496
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
|Blood|2003|361
Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia
|New England Journal of Medicine|1987|334
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|301